To determine if amino-terminal fragments of apoE can be detected in the human PD brain, an immunohistochemical study utilizing the nApoECFp17 antibody was initiated utilizing fixed substantia nigra brain sections from confirmed PD cases. This evidence concerns the gene APOE and Parkinson disease.